The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | Optimal management of intermediate-fit and frail elderly patients with myeloma & refining frailty
In this discussion, Claudia Stege, MD, and Sonja Zweegman, MD, PhD, Amsterdam UMC, Amsterdam, Netherlands, comment on the management of intermediate-fit and frail elderly patients with multiple myeloma, outlining current and emerging therapeutic strategies, and comparing frailty indexes (FIs) including the simplified frailty score and the IMWG frailty score. This discussion took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
